The Report also provides progress against our ambitious set of Health for Humanity 2025 Goals.
In 2022, we continued to focus on solving challenging global health issues that align with our ESG strategic priorities. Built on a foundation of accountability and innovation, these strategic priorities -championing global health equity, empowering our employees and advancing environmental health - guide how we work to create value for the stakeholders we serve.
Highlights from the 2022 Report include:
Championing global health equity
We strive for a healthier, more equitable future by helping to transform the future of the world's access to health care.
Delivered more than 586,000 courses of our medicine SIRTURO (bedaquiline), which is used to treat multidrug-resistant tuberculosis, since 2014.
Earned the 2 ranking in the 2022 Access to Medicine Index, reflecting our strategy to enable access to our medicines and technologies for people in low- and middle-income countries.
Supported 1.3 million nurses, midwives and community health workers with skills, tools and growth through the Johnson &
Empowering our employees
We aim to attract and attain top-tier employees by creating a future-ready organization and encouraging employees to lend their skills and expertise to create healthy communities worldwide.
Reached 36% ethnic/racial diversity in management positions within the
More than 130,000 employees (92%) responded to Our
Launched J&J Learn, a dynamic learning and development ecosystem that empowers employees with continuous opportunities for reskilling, upskilling and development.
Advancing environmental health
We advance environmental health goals in order to support a healthier planet.
Reached the milestone of 100% renewable electricity for our operations in
Included on the CDP A List for leadership in climate action for the fifth year in a row.
Launched a new multiyear collaborative initiative,
Leading with accountability and innovation
We are committed to science and data-driven decision making, compliance, integrity and responsible business practices across the value chain.
Invested
Updated Responsibility Standards for Suppliers with expanded expectations on diversity, equity and inclusion, information security, environmental responsibility and to respect and promote human rights across our operations and business.
Reporting Frameworks and Standards
The 2022 Health for Humanity Report has been prepared in accordance with the
Johnson & Johnson Environmental, Social and Governance (ESG)
At
About
At
(C) 2023 Electronic News Publishing, source